Gartner forecasts a bigger increase in world IT spending for 2025, suggesting a potential turnaround for enterprise IT spending and benefiting companies like UiPath. Automation is the key value of AI in enterprises, with UiPath's platform enabling intelligent operations, making it a compelling long-term investment. UiPath, despite a 50% stock decline in 2024, shows promise with double-digit growth and low valuation, making it a strong growth investment opportunity.
UiPath (PATH) reachead $12.35 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
UiPath NYSE: PATH is at the forefront of the enterprise automation software sector, providing powerful tools that enable businesses to automate repetitive tasks, streamline workflows, and boost overall efficiency. However, UiPath's stock price is down close to 50% year to date, which has left many investors wondering if this is a buying opportunity or a sign of further decline.
UiPath (PATH) closed at $12.77 in the latest trading session, marking a -0.23% move from the prior day.
Given the recent plummet in PATH's share price, we evaluate its current position to determine whether investors should buy, hold or sell the stock.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath is a buy due to its strong recurring revenue, high gross margins, and horizontal product relevance across industries, despite recent sales slowdowns. The company has implemented strategic changes, including leadership shifts, workforce restructuring, and new product launches, to address growth and execution challenges. UiPath's valuation is attractive at
On October 3, 2024, Hitesh Ramani, the Chief Accounting Officer of UiPath Inc (PATH, Financial), sold 25,000 shares of the company at a price of $12 per share. The transaction was documented in a recent SEC Filing.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Morgan Stanley analysts think UiPath stock could return 212% by September 2025, and Ark Invest analysts believe Roku shares could surge 712% by December 2025. UiPath is the market leader in robotic process automation software, and co-founder Daniel Dines was recently reappointed CEO to reinvigorate growth.
A customer-centric approach, coupled with product innovation using GenAI, benefits PATH.
UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus analyst price target for the stock is nearly $18, suggesting a good amount of upside for investors.